Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague

Yersinia pestis, the causative agent of pneumonic plague, induces a highly lethal infection if left untreated. Currently, there is no FDA-approved vaccine against this pathogen; however, USAMRIID has developed a recombinant fusion protein, F1-V, that has been shown to induce protection against pneum...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Biomater
Auteurs principaux: Wagner, Danielle A, Kelly, Sean M, Petersen, Andrew C, Peroutka-Bigus, Nathan, Darling, Ross J, Bellaire, Bryan H, Wannemuehler, Michael J, Narasimhan, Balaji
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012387/
https://ncbi.nlm.nih.gov/pubmed/31610342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.actbio.2019.10.016
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires